Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Patient Decision Making in the Era of Transcarotid Artery Revascularization March 4, 2024
    The National Coverage Determination (NCD) on carotid stenting by Medicare in October 2023 stipulates that patients undergo a shared decision-making (SDM) conversation with their proceduralist prior to an intervention. However, to date, there is no validated SDM tool that incorporates transcarotid artery revascularization (TCAR) into its decision platform. Our objective was to elicit patient and […]
    Brianna M. Krafcik, David H. Stone, Salvatore T. Scali, Ming Cai, Isabel A. Jarmel, Caitlin W. Hicks, Philip P. Goodney, Jesse A. Columbo
  • Intraoperative Transit Time Flow Measurement Predicts Maturation of Radiocephalic Arteriovenous Fistulas March 1, 2024
    The arteriovenous fistula (AVF) is the first choice for gaining vascular access for hemodialysis. However, 20-50% of AVFs fail within 4 months after creation. Although demographic risk factors have been described, there is little evidence on the intraoperative predictors of AVF maturation failure.The aim of this study was to assess the predictive value of intraoperative […]
    E.P. de Winter, E.D. Wilschut, K. Plasmans, D.E. Eefting, T.J. van der Steenhoven, H. Putter, J.I. Rotmans, K.E.A. van der Bogt
  • Reversing spinal cord ischemia after complex aortic reconstruction: A breath of fresh air? March 1, 2024
    To many, both patients and clinicians, spinal cord ischemia (SCI) after complex aortic reconstruction (CAR) is the most devastating outcome. Avoiding SCI is therefore a key goal of treatment but one that has proved elusive. In this issue of the Journal, Lee et al report a series using hyperbaric oxygen therapy (HBOT) to reverse SCI following […]
    Linda M. Reilly
  • Large-bore Aspiration Thrombectomy Efficacy and Safety Compared with Other Thrombectomy Modalities in the Treatment of Proximal Lower Extremity Deep Vein Thrombosis March 1, 2024
    Venous thromboembolism continues to be a source of significant morbidity and mortality particularly with iliofemoral deep vein thrombosis (DVT). Technological advances in mechanical and aspiration thrombectomy over the past several years have led to questions regarding the need for thrombolytics in these patients. We aimed to evaluate patients with acute iliofemoral DVT who underwent intervention […]
    Joshua Meredith, Adam Reichard, Joshua Hernandez, Mark Broering, Brian Kuhn, Aaron Kulwicki, Matthew Recht, Patrick Muck, Angela Fellner
  • Long-Term Outcomes in the Smoking Claudicant after Peripheral Vascular Interventions March 1, 2024
    Emphasis on tobacco cessation given the urgent and emergent nature of vascular surgery is less prevalent than standard elective cases such as hernia repairs, cosmetic surgery, and bariatric procedures. The goal of this study is to determine the effect of active smoking on claudicating individuals undergoing peripheral vascular interventions (PVI). Our goal is to determine […]
    Rohini J. Patel, Sina Zarrintan, Nishita R. Vootukuru, Shatha H. Allah, Ann Gaffey, Mahmoud B. Malas
  • Implementation of a Statewide EVAR Surveillance Program Improves Long-term Follow-up and Survival March 1, 2024
    National guidelines recommend long-term surveillance after endovascular abdominal aortic aneurysm repair (EVAR) to monitor for endoleaks, graft migration, or device failure. However, multiple investigations have demonstrated that EVAR follow-up can vary greatly. Recently, the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) implemented a performance metric, linked with financial reimbursement, designed to improved EVAR […]
    Frank M. Davis, Jeremy Albright, Loay Kobbani, Hue Thai, Tamer Boules, Jordan Knepper, Nicolas Mouawad, Nicholas Osborne
  • Impact of Preoperative Risk Factors on 5-year Survival after F/BEVAR March 1, 2024
    To investigate which preoperative factors are most impactful on the 5-year survival of patients undergoing fenestrated/branched endovascular aortic repair (F/BEVAR) and to identify modifiable elements that, if time allows, should be actively managed and adequately controlled preoperatively.
    Vivian Carla Gomes, F. Ezequiel Parodi, Sydney E. Browder, Priya Vasan, Dichen Sun, William Marston, Luigi Pascarella, Katharine McGinigle, Jacob C. Wood, Mark A. Farber